20-16427128-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_ModerateBP6_Moderate
The NM_024704.5(KIF16B):c.1588G>A(p.Val530Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000035 in 1,456,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_024704.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KIF16B | NM_024704.5 | c.1588G>A | p.Val530Met | missense_variant | Exon 15 of 26 | ENST00000354981.7 | NP_078980.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KIF16B | ENST00000354981.7 | c.1588G>A | p.Val530Met | missense_variant | Exon 15 of 26 | 1 | NM_024704.5 | ENSP00000347076.2 | ||
| KIF16B | ENST00000408042.5 | c.1588G>A | p.Val530Met | missense_variant | Exon 15 of 23 | 1 | ENSP00000384164.1 | |||
| KIF16B | ENST00000636835.1 | c.1588G>A | p.Val530Met | missense_variant | Exon 15 of 25 | 1 | ENSP00000489838.1 | |||
| KIF16B | ENST00000635823.2 | c.1588G>A | p.Val530Met | missense_variant | Exon 15 of 23 | 5 | ENSP00000490639.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000162 AC: 4AN: 247348 AF XY: 0.0000224 show subpopulations
GnomAD4 exome AF: 0.0000350 AC: 51AN: 1456130Hom.: 0 Cov.: 31 AF XY: 0.0000345 AC XY: 25AN XY: 724150 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Prostate cancer Uncertain:1
- -
not specified Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at